302 related articles for article (PubMed ID: 18221232)
1. Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Judge SI; Smith PJ; Stewart PE; Bever CT
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):200-28. PubMed ID: 18221232
[TBL] [Abstract][Full Text] [Related]
2. Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.
Judge SI; Smith PJ
Expert Opin Ther Pat; 2009 Apr; 19(4):433-60. PubMed ID: 19441925
[TBL] [Abstract][Full Text] [Related]
3. Potassium channels and pain: present realities and future opportunities.
Ocaña M; Cendán CM; Cobos EJ; Entrena JM; Baeyens JM
Eur J Pharmacol; 2004 Oct; 500(1-3):203-19. PubMed ID: 15464034
[TBL] [Abstract][Full Text] [Related]
4. KATP channel openers: structure-activity relationships and therapeutic potential.
Mannhold R
Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
6. Research into the therapeutic roles of two-pore-domain potassium channels.
Es-Salah-Lamoureux Z; Steele DF; Fedida D
Trends Pharmacol Sci; 2010 Dec; 31(12):587-95. PubMed ID: 20951446
[TBL] [Abstract][Full Text] [Related]
7. Potassium channels in brain mitochondria.
Bednarczyk P
Acta Biochim Pol; 2009; 56(3):385-92. PubMed ID: 19759922
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of cardiac potassium channels.
Snyders DJ
Cardiovasc Res; 1999 May; 42(2):377-90. PubMed ID: 10533574
[TBL] [Abstract][Full Text] [Related]
9. A unique alkaline pH-regulated and fatty acid-activated tandem pore domain potassium channel (K₂P) from a marine sponge.
Wells GD; Tang QY; Heler R; Tompkins-MacDonald GJ; Pritchard EN; Leys SP; Logothetis DE; Boland LM
J Exp Biol; 2012 Jul; 215(Pt 14):2435-44. PubMed ID: 22723483
[TBL] [Abstract][Full Text] [Related]
10. Potassium channel openers as potential therapeutic weapons in ion channel disease.
Lawson K
Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
[TBL] [Abstract][Full Text] [Related]
11. Medicinal Chemistry of Potassium Channel Modulators: An Update of Recent Progress (2011-2017).
Vyas VK; Parikh P; Ramani J; Ghate M
Curr Med Chem; 2019; 26(12):2062-2084. PubMed ID: 29714134
[TBL] [Abstract][Full Text] [Related]
12. Researches toward potassium channels on tumor progressions.
Shen Z; Yang Q; You Q
Curr Top Med Chem; 2009; 9(4):322-9. PubMed ID: 19442203
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular system.
Wiedmann F; Schmidt C; Lugenbiel P; Staudacher I; Rahm AK; Seyler C; Schweizer PA; Katus HA; Thomas D
Clin Sci (Lond); 2016 May; 130(9):643-50. PubMed ID: 26993052
[TBL] [Abstract][Full Text] [Related]
14. ATP-sensitive K+ channel openers: old drugs with new clinical benefits for the heart.
Miura T; Miki T
Curr Vasc Pharmacol; 2003 Oct; 1(3):251-8. PubMed ID: 15320472
[TBL] [Abstract][Full Text] [Related]
15. The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.
Jensen BS; Hertz M; Christophersen P; Madsen LS
Expert Opin Ther Targets; 2002 Dec; 6(6):623-36. PubMed ID: 12472376
[TBL] [Abstract][Full Text] [Related]
16. Gating the pore of potassium leak channels.
Cohen A; Ben-Abu Y; Zilberberg N
Eur Biophys J; 2009 Dec; 39(1):61-73. PubMed ID: 19404634
[TBL] [Abstract][Full Text] [Related]
17. [Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].
Devaux J; Beeton C; Béraud E; Crest M
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S16-27. PubMed ID: 15269656
[TBL] [Abstract][Full Text] [Related]
18. K(+) channels as therapeutic drug targets.
Wickenden A
Pharmacol Ther; 2002; 94(1-2):157-82. PubMed ID: 12191600
[TBL] [Abstract][Full Text] [Related]
19. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.
Bayliss DA; Barrett PQ
Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
